Market Overview

UPDATE: Wellington Shields Upgrades Clorox Products to Buy on Favorable Outlook

Related CLX
P&G Tides Over Macro Challenges: Can It Survive In 2015?
UPDATE: Credit Suisse Reiterates On The Clorox Co As FY15 Is Off To Good Start
Making Money With Charles Payne: 11/17/14 (Fox Business)

Wellington Shields upgraded Clorox Products (NYSE: CLX) from Hold to Buy and raised the price target to $95.00.

Wellington Shields analyst Leigh Ferst noted, "We have raised our outlook for CLX, moving the price target up to 95 and the rating back to a Buy. We believe that the top line momentum, improving margins and cash flow, and better market conditions, leave the company with room to beat expectations, improve its long term growth assumptions, and enjoy a higher valuation as a result. Using a FY14 EPS assumption of 4.75 and an estimated forward PE of 20 brings us a new price target of 95. Clorox seems to be charging ahead on all cylinders and we think the continuing positive business momentum should lead to higher valuation for the shares."

Clorox Products closed at $83.72 on Friday.

Latest Ratings for CLX

DateFirmActionFromTo
Dec 2014CitigroupMaintainsNeutral
Dec 2014Raymond JamesInitiates Coverage onMarket Perform
Nov 2014Credit SuisseMaintainsUnderperform

View More Analyst Ratings for CLX
View the Latest Analyst Ratings

Posted-In: Wellington ShieldsAnalyst Color Upgrades Analyst Ratings

 

Related Articles (CLX)

Around the Web, We're Loving...

Get Benzinga's Newsletters